Cargando…
Disease- and treatment-associated acquired glucocorticoid resistance
The development of resistance to glucocorticoids (GCs) in therapeutic regimens poses a major threat. Generally, GC resistance is congenital or acquired over time as a result of disease progression, prolonged GC treatment or, in some cases, both. Essentially, disruptions in the function and/or pool o...
Autores principales: | Wilkinson, Legh, Verhoog, Nicolette J D, Louw, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280593/ https://www.ncbi.nlm.nih.gov/pubmed/30352419 http://dx.doi.org/10.1530/EC-18-0421 |
Ejemplares similares
-
Novel role for receptor dimerization in post-translational processing and turnover of the GRα
por: Wilkinson, Legh, et al.
Publicado: (2018) -
Acquired Glucocorticoid Resistance Due to Homologous Glucocorticoid Receptor Downregulation: A Modern Look at an Age-Old Problem
por: Spies, Lee-Maine L., et al.
Publicado: (2021) -
The Association of Acute Phase Proteins in Stress and Inflammation-Induced T2D
por: Speelman, Tammy, et al.
Publicado: (2022) -
Inhibition of Corticosteroid-Binding Globulin Gene Expression by Glucocorticoids Involves C/EBPβ
por: Verhoog, Nicolette, et al.
Publicado: (2014) -
Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells
por: van Dyk, Lorinda, et al.
Publicado: (2022)